Rat Hepatitis E Virus: An Emerging Zoonotic Threat to Human Health
For decades, medical professionals attributed human hepatitis E infections almost exclusively to the Paslahepevirus balayani genus. However, a genetically distinct virus known as Rocahepevirus ratti—commonly referred to as rat hepatitis E virus (rat HEV)—has emerged as a significant zoonotic risk. Recent evidence suggests this virus is spilling over into human populations more frequently than previously recognized, posing a “hidden” cause of hepatitis worldwide.
- Rat HEV (Rocahepevirus ratti) is a zoonotic virus that can infect humans.
- Recent cases include severe acute hepatitis in immunocompetent patients and chronic hepatitis in transplant recipients.
- Spillover risk is significantly higher in biodiversity hotspots, such as Yunnan province in China.
- New diagnostic methods, such as the DARE method, are essential for distinguishing rat HEV from other strains.
Understanding Rat Hepatitis E Virus (rat HEV)
Hepatitis E virus (HEV) is a leading cause of acute viral hepatitis globally, accounting for an estimated 20 million infections and 40,000 deaths annually. Although most cases were historically linked to specific human genotypes, the identification of Rocahepevirus ratti has shifted the understanding of the virus’s epidemiology. Rats serve as the natural reservoirs for this pathogen, and the virus can jump from these rodents to humans through spillover events.
Clinical Impact and Global Cases
The impact of rat HEV on human health can vary from mild to severe. According to reports in the Journal of Infectious Diseases, the virus has been implicated in several critical clinical scenarios:
- Severe Acute Hepatitis: Cases have been reported in immunocompetent patients in Spain and Canada.
- Chronic Hepatitis: A case of chronic infection was identified in a liver transplant patient in Hong Kong.
- Asymptomatic Exposure: Many individuals may carry antibodies without showing severe symptoms, masking the true extent of the virus’s spread.
The Role of Biodiversity Hotspots in Transmission
Research indicates that the risk of rat HEV spillover isn’t uniform across all regions. A large-scale population analysis published in Nature Communications highlighted a stark difference in exposure based on geography. In Yunnan province, China—a recognized biodiversity hotspot—exposure risks were significantly higher. Data showed that 21.97% of hospital visitors and 13.97% of those with ALT abnormalities in Yunnan tested positive for rat HEV exposure. In contrast, a control region in Jiangsu province showed an exposure rate of only 0.75%.
Challenges in Diagnosis and Surveillance
One of the primary reasons rat HEV has remained a “hidden” cause of hepatitis is the difficulty in distinguishing it from other HEV genotypes. To address this, researchers developed the Distinguishing Antibody Response Elicitation (DARE) method. This serological test allows clinicians to specifically identify exposure to rat HEV, providing a vital tool for proactive surveillance and the management of public health emergencies.
Comparison of HEV Types
| Feature | Traditional HEV | Rat HEV (rHEV) |
|---|---|---|
| Genus | Paslahepevirus balayani | Rocahepevirus ratti |
| Primary Reservoir | Humans/Various animals | Rats |
| Diagnostic Need | Standard HEV assays | Specialized tests (e.g., DARE method) |
Frequently Asked Questions
How is rat HEV transmitted to humans?
Rat HEV is a zoonotic virus, meaning it spreads from animals (specifically rats) to humans. While the exact mechanisms of every spillover event are still being studied, the close relationship between strains found in rats and those found in human infections confirms the rodent reservoir.
Can rat HEV cause chronic illness?
Yes. While many cases are acute, there is evidence of chronic hepatitis occurring in specific vulnerable populations, such as liver transplant patients.
Why is it called a “hidden” cause of hepatitis?
It’s considered hidden as standard diagnostic tests may not distinguish rat HEV from other genotypes, leading to underreporting and a lack of awareness regarding the true global burden of the virus.
Looking Ahead
The emergence of Rocahepevirus ratti underscores the ongoing threat of zoonotic spillover in an interconnected world. As diagnostic tools like the DARE method become more widely available, public health officials will be better equipped to monitor these infections, particularly in biodiversity hotspots. Continued surveillance is critical to prevent larger outbreaks and to develop targeted strategies for protecting high-risk populations.